SESEN BIO INC's ticker is SESN and the CUSIP is 817763105. A total of 71 filers reported holding SESEN BIO INC in Q3 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | – | 418 | -61.2% | 0.00% | – |
| Q3 2022 | $0 | – | 1,076 | +266.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 294 | -97.9% | 0.00% | – |
| Q1 2022 | $8,000 | -78.9% | 14,068 | -69.9% | 0.00% | – |
| Q4 2021 | $38,000 | +123.5% | 46,720 | +108.3% | 0.00% | – |
| Q3 2021 | $17,000 | -69.1% | 22,428 | +89.5% | 0.00% | – |
| Q2 2021 | $55,000 | – | 11,836 | +9763.3% | 0.00% | – |
| Q1 2021 | $0 | – | 120 | +11900.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 1 | -99.9% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 1,366 | -61.2% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 3,521 | +9.5% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 3,216 | +151.8% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 1,277 | -10.2% | 0.00% | – |
| Q3 2019 | $2,000 | +100.0% | 1,422 | +184.4% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -91.7% | 500 | -91.0% | 0.00% | – |
| Q3 2018 | $12,000 | +1100.0% | 5,541 | +1008.2% | 0.00% | – |
| Q2 2018 | $1,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BLODGETT WEALTH ADVISORS, LLC | 327,900 | $139,000 | 0.17% |
| GSA CAPITAL PARTNERS LLP | 188,626 | $80,000 | 0.01% |
| Investment Advisory Group, LLC | 20,000 | $9,000 | 0.01% |
| Stratos Wealth Partners, LTD. | 413,130 | $176,000 | 0.01% |
| WealthTrust Axiom LLC | 31,750 | $13,000 | 0.01% |
| CSS LLC/IL | 165,086 | $70,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 250,000 | $106,000 | 0.00% |
| CAPITAL PERFORMANCE ADVISORS LLP | 10,000 | $4,000 | 0.00% |
| Virtu Financial LLC | 72,808 | $31,000 | 0.00% |
| OXFORD FINANCIAL GROUP, LTD. LLC | 30,000 | $13,000 | 0.00% |